UNICREDIT BANK/PUT/ELI LILLY & CO/1000/0.1/17.12.25 | Market Closed - BOERSE MUENCHEN 20:41:48 28/06/2024 BST | ||
| 15.07 EUR | -2.27% |
|
| Current month | -24.57% | ||
| 1 month | -27.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 15.07 | -2.27% |
| 27/06/24 | 15.42 | -0.58% |
| 26/06/24 | 15.51 | 0.00% |
| 25/06/24 | 15.51 | -2.39% |
| 24/06/24 | 15.89 | -2.63% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 08:41 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD31WT |
| ISIN | DE000HD31WT3 |
| Date issued | 26/02/2024 |
| Strike | 1,000 $ |
| Maturity | 17/12/2025 (536 Days) |
| Parity | 10 : 1 |
| Emission price | 23.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 27 € |
|---|---|
| Lowest since issue | 15.07 € |
| Spread | 0.36 € |
| Spread % | 2.35% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Warrants
- Warrant
